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The proper extracytoplasmic localization of proteins is an important aspect of mycobacterial physiology and
the pathogenesis of Mycobacterium tuberculosis. The protein export systems of mycobacteria have remained
unexplored. The Sec-dependent protein export pathway has been well characterized in Escherichia coli and is
responsible for transport across the cytoplasmic membrane of proteins containing signal sequences at their
amino termini. SecA is a central component of this pathway, and it is highly conserved throughout bacteria.
Here we report on an unusual property of mycobacterial protein export—the presence of two homologues of
SecA (SecA1 and SecA2). Using an allelic-exchange strategy in Mycobacterium smegmatis, we demonstrate that
secA1 is an essential gene. In contrast, secA2 can be deleted and is the first example of a nonessential secA
homologue. The essential nature of secA1, which is consistent with the conserved Sec pathway, leads us to
believe that secA1 represents the equivalent of E. coli secA. The results of a phenotypic analysis of a secA2
mutant of M. smegmatis are presented here and also indicate a role for SecA2 in protein export. Based on our
study, it appears that SecA2 can assist SecA1 in the export of some proteins via the Sec pathway. However,
SecA2 is not the functional equivalent of SecA1. This finding, in combination with the fact that SecA2 is highly
conserved throughout mycobacteria, suggests a second role for SecA2. The possibility exists that another role
for SecA2 is to export a specific subset of proteins.
Mycobacterium tuberculosis is the causative agent of tuber-
culosis and represents a severe health threat throughout the
world. Nearly three million people die each year from tuber-
culosis (51). M. tuberculosis is an intracellular pathogen that is
able to survive and grow in macrophages. Secreted and cell
surface-associated proteins are ideally positioned to act on the
host macrophage and enable survival of the bacillus in this
normally hostile antimicrobial environment. In support of this
hypothesis, the exported repetitive protein (Erp) has been
shown to participate in the pathogenesis of M. tuberculosis (2).
An erp mutant of M. tuberculosis is attenuated in mice and
exhibits a significantly reduced ability to grow in macrophages.
However, the specific role of Erp in the intracellular survival
strategy of M. tuberculosis is unknown.
Protein export is an important aspect of bacterial pathogen-
esis. Research on diverse bacterial pathogens has demon-
strated that the majority of virulence factors are extracytoplas-
mic proteins (20, 29). Recently, the importance of protein
export pathways to pathogenicity has been underscored by the
identification of specialized secretion pathways (types I, II, III,
and IV) in numerous bacterial pathogens. There are many
examples of these types of export pathways being encoded in
pathogenicity islands and being required for the proper local-
ization of specific virulence factors (28).
Surprisingly little is known about the protein export path-
ways of mycobacteria (4). In contrast, the protein export path-
ways of other bacteria are better characterized, most notably in
Escherichia coli (11, 15). The Sec-dependent protein export
pathway is responsible for the transport of the majority of
extracytoplasmic proteins in E. coli; consequently, this export
system represents an essential function of the cell (16). The
proteins translocated across the cytoplasmic membrane by the
Sec pathway are initially synthesized as precursor proteins con-
taining conserved amino-terminal signal sequences. These pre-
cursor proteins are routed to the translocase, the channel
through which translocating proteins travel across the mem-
brane. During translocation, the signal sequence is cleaved off
by a signal peptidase to generate the mature exported protein.
The translocase core is composed of integral membrane pro-
teins SecY and SecE and the peripheral membrane protein
SecA. SecA plays a central and essential role in this export
pathway. It is an ATPase that provides energy for protein
translocation. In addition, SecA binds to nearly all of the com-
ponents of the Sec pathway, including precursor proteins,
chaperones such as SecB, acidic phospholipids in the mem-
brane, and integral membrane components of the translo-
case (15, 33, 43). Through cycles of ATP binding and hydro-
lysis, SecA delivers bound precursor proteins to the translocase
and undergoes cycles of membrane insertion and deinsertion
that lead to stepwise export of the protein (18, 42, 50). Addi-
tional proteins, SecG and the complex of SecD, SecF, and
YajC, are not essential to Sec-dependent export but serve to
increase the overall efficiency of the process (14). The Sec-
dependent export pathway is highly conserved among different
bacteria (39, 43).
In order to begin understanding the protein export pathways
that operate in mycobacteria, we set out to identify and char-
acterize SecA. To our surprise, there are two homologues of
secA in mycobacteria, referred to as secA1 and secA2. This was
an unexpected finding, as no other fully sequenced genome,
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among those available at the time, had revealed the existence
of two secA genes in a single organism. In this report, we
present a genetic analysis in Mycobacterium smegmatis, a fast-
growing and nonpathogenic mycobacteria, that demonstrates
that the two mycobacterial secA genes are not redundant and
that both function in the cell.
Very recently, the Staphylococcus aureus and Streptococcus
pneumoniae genomes provided two additional examples of
bacteria that possess two secA genes (24, 27, 48). The presence
of two SecA proteins may represent a new type of specialized
protein export pathway.
MATERIALS AND METHODS
Bacterial strains and culture methods. All of the strains used in this work are
described in Table 1. E. coli strain DH5 was used for DNA cloning procedures.
For culturing of E. coli, Luria-Bertani (LB) broth or agar (Difco) was used.
When required, the following antibiotics were used for E. coli strains: kanamycin
at 40 g/ml and carbenicillin at 50 g/ml. A variety of media were employed for
the growth of M. smegmatis and included all of the following: Middlebrook 7H9
broth (Difco) with 0.2% glycerol, 0.5% dextrose, and 0.1% Tween 80; the same
medium supplemented with 0.2% glycerol, 1 ADS (0.5% bovine serum albu-
min, fraction V [Boehringer Mannheim], 0.2% dextrose, 0.85% NaCl), and 0.1%
Tween 80; LB broth with 0.1% Tween 80; 7H10 agar with 0.2% dextrose and
0.05% Tween 80; LB agar with 0.2% dextrose; and Mueller-Hinton agar (Difco).
When appropriate, sucrose was incorporated into 7H10 plates at a concentration
of 4.5%. When required, the following antibiotics were used to grow M. smeg-
matis strains: kanamycin at 20 g/ml and hygromycin B at 50 g/ml. When
appropriate, cultures were grown overnight in Middlebrook 7H9 with 0.2%
glycerol, 1 ADS, 0.1% Tween 80, and 100 M sodium azide.
DNA methodologies. Standard molecular biology techniques for cloning were
employed as previously described (41). Restriction enzymes and Vent polymer-
ase were obtained from New England Biolabs, Inc. The Expand high fidelity PCR
system was obtained from Boehringer Mannheim. Dimethyl sulfoxide (1.0 to
10.0%) was included in selected PCRs. DNA sequencing was performed by
conventional and automated methods. Automated sequencing employed the
Applied Biosystems Big Dye Terminator Cycle Sequencing kit (Perkin-Elmer)
and an Applied Biosystems 377 sequencer. Sequence assembly was carried out
with the MacVector and Assembly Align software (Genetics Computer Group).
Plasmid construction. The plasmids used in this study are described in Table 2.
Cloning and sequencing of secA1 homologues. Degenerate oligonucleotide
primers were designed to regions of identity in the secA genes of E. coli, Bacillus
subtilis, and Pavlova lutherii. The 5 primer (5-ACN-GGN-GAX-GGN-AAX-A
CN-YT-3) was designed from the peptide TGEGKT (amino acids 104 to 109 of
the E. coli sequence), and the 3 primer (5-AXX-TAX-TCX-AAN-CC-3) was
designed from the peptide GFDYL (amino acids 183 to 187 of the E. coli
sequence), where N  GAT or C, X  G or A, and Y  C or T. These primers
were employed in a touchdown PCR (40) to amplify 250-bp products from M.
bovis BCG and M. smegmatis genomic DNAs.
To clone the full-length genes, the resulting PCR products were used as probes
to screen the appropriate libraries. The M. bovis BCG product was used to screen
a pKSII::M. bovis BCG library (7). One hybridizing clone, pH.3, was subjected
to exonuclease digestion to generate a collection of nested deletions, by using the
Erase-A-Base system (Promega), that were then sequenced. The M. smegmatis
product was used to screen a pYUB282::mc2155 cosmid library (kind gift of V.
Balasubramanian). A 4.0-kb fragment from one hybridizing clone, pYUB495,
was subcloned into pKSII to generate pYUB536. Nested deletions of
pYUB536 were constructed with the Erase-A-Base system and sequenced.
Cloning and sequencing of secA2 homologues. Full-length M. tuberculosis
secA2 was amplified by PCR from M. tuberculosis H37Rv genomic DNA by using
primers SecAS14 (5 TCGGATC-CAGCGGAACACCCCGGGCAGACT) and
SecAS15 (5GCGGATCCAGTGCACGGTTGTCCACGAATTGC). The PCR
product was cloned into the pCR2.1 vector by using the TA cloning kit (Invitro-
gen) to generate pMB144. This PCR product was used to probe a pYUB412::M.
smegmatis genomic cosmid library (kind gift of F. C. Bange) under low-stringency
conditions. A 6.0-kb fragment from one hybridizing clone, p6-1, was subcloned
into pSKII to generate pMB148. Nested deletions of pMB148 were con-
structed with the Erase-A-Base system and used to generate the sequence of
secA2 (M. smegmatis).
To clone M. smegmatis secA2 under the control of the constitutive hsp60
promoter, the gene was amplified by PCR from M. smegmatis mc2155 genomic
DNA. The primers used were SmSecA2-14 (5ACGGATCCA-GTGGCGAAT
GAGTCCTGGCGAAC) and SmSecA2-13 (5CGTCTTCCATGCCTAGAAC-
CTAATG). The resulting PCR product was cloned in pCR2.1 to create pMB207.
The BamHI fragment containing secA2 was then subcloned into pMV261 to
create pMB208.
Construction of secA suicide plasmids. (i) secA1 suicide plasmid pMB128.
An approximately 12.0-kb SacI fragment of pYUB495 containing secA1 of M.
smegmatis was identified by Southern analysis. Restriction digest analysis showed
that secA1 is located near the middle of this fragment. This fragment was cloned
into pKSII to generate plasmid pMB117. pMB117 was linearized with BglII (a
unique site near the middle of secA1) and then subjected to exonuclease III
digestion in both directions outward from the BglII-cut site by using the Erase-
A-Base system and self-ligated. One of the resulting deletion constructs,
pMB120, was analyzed by PCR and sequencing analysis and shown to contain a
1,278-bp in-frame deletion of the secA1 gene. The large SacI fragment of
pMB120 was subcloned into pSKII to create pMB125. The in-frame unmarked
secA1 deletion fragment was then cloned into counterselectable suicide vector
pYUB657 (37). This was achieved by cutting pMB125 with SpeI and ScaI and
cloning the resulting secA1 fragment into SpeI- and ScaI-cut pYUB657. The final
vector produced was pMB128.
(ii) secA2 suicide plasmid pMB160. A 3.2-kb BamHI-ScaI fragment of
pMB148 was cloned into BamHI-EcoRV-cut pKSII to generate pMB155.
pMB155 was used as the template in an inverse PCR using primers SmSecA2-5
TABLE 1. Strains used in this study
Strain Description Reference





MB526 mc2155::pMB128, secA1 single-crossover strain This work
MB573 mc2155::pMB160, secA2 single-crossover strain This work
mc22522 mc2155, 	secA2 This work
mc22718 mc2155, attB::fbpB-Tn552 phoA oriE1 kan 5
mc22724 mc2155, attB::pepA-Tn552  phoAl oriE1 hyg 5
mc22725 mc2155, attB::rv1566c-Tn552 phoA-oriE1-kan 5
mc22757 mc2155 (pMB174), expresses phoA 5
MB509 mc2155(pMV261) This work
MB624 mc2155(pMB196), expresses a pepA-phoA fusion This work
MB625 mc22522(pMB196), expresses a pepA-phoA fusion This work
MB634 mc2155(pMB202), expresses a rv1566c-phoA fusion This work
MB635 mc22522(pMB202), expresses a rv1566c-phoA fusion This work
MB648 mc2155(pMB206), expresses a fbpB-HA-phoA fusion This work
MB649 mc22522(pMB206), expresses a fbpB-HA-phoA fusion This work
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(5-ACTGATATCGCGCAGCACGTCGAAGCCGAT-3) and SmSecA2-6 (5-
TGAGATATCGTCGAGCGCCGCGAGACCCT-3) (underlined residues de-
note the EcoRV site). The resulting PCR product was gel purified, cut with
EcoRV, and self-ligated. The resulting vector was pMB156. Due to primer
locations in secA2, pMB156 contains an in-frame deletion of 1,296 bp in secA2.
A SpeI-ScaI secA2-containing fragment of pMB156 was subcloned into SpeI-
ScaI-cut pYUB657. The final vector was pMB160.
Electroporation of M. smegmatis. M. smegmatis strain mc2155 (45) was elec-
troporated as previously described (36).
Two step allelic exchange to create secA mutants of M. smegmatis. To con-
struct 	secA1 mutants, pMB128 was electroporated into mc2155 and hygromy-
cin-resistant transformants were selected. Individual transformants were sub-
jected to Southern analysis, and 14 out of the 16 strains evaluated contained the
suicide vector integrated into the secA1 region of the chromosome by means of
a single-crossover event. One of these strains, MB526, was employed in the
subsequent steps. For the second homologous recombination event, MB526 was
first grown to saturation in 7H9 medium with hygromycin at 50 g/ml. For
MB526 strains that additionally carry kanamycin resistance element-containing
TABLE 2. Plasmids used in this study
Plasmid Phenotype/genotype Description Source
pKSII bla ColE1 Stratagene
pSKII bla ColE1 Stratagene
pCR2.1 bla aph ColE1 Invitrogen
pMV261.kan aph Phsp60 oriM ColE1 Multicopy mycobacterial shuttle plasmid 46
pMV306.kan aph int attP ColE1 Single-copy mycobacterial shuttle plasmid 46
pMV361.hyg hyg Phsp60 int attP ColE1 Single-copy mycobacterial shuttle plasmid 46
pYUB412 bla hyg int attP ColE1 cos
 Single-copy mycobacterial shuttle plasmid S. Bardarov and W. R. Jacobs
pYUB282 bla ColE1 cos
 V. Balasubramanian and
W. R. Jacobs
pMD31 aph oriM ColE1 Multicopy mycobacterial shuttle plasmid 12
pMB198 hyg int attP ColE1 Phsp60 deleted from pMV361.hyg This work
pYUB657 bla hyg Phsp60-sacB ColE1 Counterselectable suicide vector for mycobacteria 37
pYUB495 bla secA1 (M. smegmatis) ColE1
cos
y
pYUB282 containing M. smegmatis secA1 This work
pYUB536 bla secA1 (M. smegmatis) ColE1 4.0-kb BamHI fragment containing M. smegmatis secA1 from
pYUB495 cloned in pKSII
This work
pYUB544 aph Phsp60-secA1 oriM ColE1 4.0-kb BamHI fragment from pYUB536 cloned into pMV261;
M. smegmatis secA1 under control of hsp60 promoter
This work
pH.3 bla secA1 (M. bovis BCG) ColE1 pKSII containing an 8.0-kb fragment with M. bovis BCG secA1 This work
pYUB499 aph secA1 (M. bovis BCG) oriM
ColE1
3.0-kb HindIII-KpnI fragment of M. bovis BCG secA1 cloned
into pMD31
This work
pYUB538 aph secA1AzR (M. bovis BCG)
oriM ColE1
pYUB499 with secA1 azide resistance allele This work
pMB117 bla secA1 (M. smegmatis) ColE1 12.0-kb SacI fragment containing M. smegmatis secA1 from
pYUB495 cloned into pKSII
This work
pMB120 bla 	secA1 (M. smegmatis) ColE1 In-frame deletion mutant form of secA1 derived from pMB117 This work
pMB125 bla 	secA1 (M. smegmatis) ColE1 SacI fragment of pMB120 subcloned into pSKII This work
pMB128 bla hyg Phsp60-sacB 	secA1
(M. smegmatis) ColE1
	secA1 from pMB125 cloned into pYUB657 This work
p6-1 bla secA2 (M. smegmatis) ColE1 pYUB412 cosmid containing M. smegmatis secA2 This work
pMB144 bla aph secA2 (M. tuberculosis)
ColE1
M. tuberculosis secA2 cloned into pCR2.1 This work
pMB147 aph Phsp60-secA2 (M. tuberculosis)
oriM ColE1
M. tuberculosis secA2 from pMB144 cloned into pMV261 under
control of Phsp60
This work
pMB148 bla secA2 (M. smegmatis) ColE1 6.0-kb BamHI fragment from p6-1 containing M. smegmatis
secA2 cloned into pSKII
This work
pMB155 bla secA2 (M. smegmatis) ColE1 3.2-kb BamHI-ScaI fragment of pMB148 carrying M. smegmatis
secA2 cloned into pKSII
This work
pMB156 bla 	secA2 (M. smegmatis) ColE1 In-frame deletion of secA2 derived from pMB155 This work
pMB160 bla hyg Phsp60-sacB 	secA2
(M. smegmatis) ColE1
	secA2 cloned from pMB156 into pYUB657 This work
pMB162 aph Phsp60-secA2 (M. tuberculosis)
int attP ColE1
HindIII-XbaI fragment carrying Phsp60-secA2 from pMB147 sub-
cloned into pMV306.kan
This work
pMB110 aph Phsp60-phoA oriM ColE1 phoA PCR product cloned under control of Phsp60 This work
pMB174 aph Phsp60-phoA int attP ColE1 NotI fragment of pMB110 carrying Phsp60-phoA cloned into
pMV306.kan
This work
pMB175 aph secA1 (M. bovis BCG) int
attP ColE1
HindIII/Asp718 M. bovis BCG secA1 containing fragment cloned
into pMV306.kan
This work
pMB196 aph pepA::Tn552 phoA oriE1 hyg
int attP ColE1
pepA::phoA fusion recovered as NheI fragment from mc22724
cloned into pMB198
This work
pMB202 hyg rv1566c::Tn552 phoA oriE1
kan int attP ColE1
rv1566c::phoA fusion recovered as NarI fragment from mc22725
cloned into pMB198
This work
pMB203 hyg fbpB::Tn552 phoA oriE kan
int attP ColE1
fbpB::phoA fusion recovered as NarI fragment from mc22718
cloned into pMB198
This work
pMB206 hyg fbpB-HA::Tn552 phoA oriE1
kan int attP ColE1
HA tag cloned in frame into fbpB::phoA fusion in pMB203 This work
pMB207 bla aph secA2 (M. smegmatis)
ColE1
M. smegmatis secA2 cloned into pCR2.1 This work
pMB208 aph Phsp60-secA2 (M. smegmatis)
oriM ColE1
M. smegmatis secA2 from pMB207 cloned into pMV261 under
control of Phsp60
This work
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plasmids, kanamycin was included in this medium. This culture was subcultured
at a 1:100 dilution into the same medium lacking hygromycin and incubated
overnight. Dilutions were plated onto 7H10 plates containing 4.5% sucrose to
select for sucrose-resistant colonies. To obtain 	secA2 mutants, pMB160 was
electroporated into mc2155 and hygromycin-resistant transformants were ob-
tained. Three out of three transformants were confirmed to be the result of a
single-crossover event by Southern analysis. One of these clones, MB573, was
used for the subsequent work presented in this report. The second homologous
recombination event was selected by using the protocol described above for
MB526.
Southern analysis. To analyze secA1 recombinants, genomic DNA was iso-
lated from M. smegmatis clones as previously described (10) and digested with
BglII. The probe used was a 669-bp MscI fragment of pYUB536 containing secA1
of M. smegmatis. To analyze secA2 recombinants, genomic DNA was isolated and
digested with BamHI. The probe used was a 1.9-kb BamHI-HindIII fragment
obtained from pMB156 that contains secA2 of M. smegmatis. Southern analysis
was performed as previously described (41), and probes were labeled with
[32P]dCTP using the Ready-to-Go Labeling kit (Pharmacia).
Construction of phoA fusion vectors. fbpB-phoA, pepA-phoA, and rv1566c-
phoA fusions were rescued from strains mc22718, mc22724, and mc22725, re-
spectively. These strains contain M. tuberculosis DNA-phoA fusions that encode
active PhoA fusion proteins in M. smegmatis and were recently obtained from
transposon libraries (5). These phoA fusions are present on cosmids integrated
into the chromosome. To rescue the fusions, genomic DNA was isolated from
each strain and digested with NarI (for mc22718 and mc22725) or NheI (for
mc22724), self-ligated, and transformed into DH5. Due to the presence of an E.
coli origin of replication on the transposon, these self-ligated molecules are
replicative plasmids in E. coli. These restriction enzymes cut outside of the phoA
fusion and promoter element. Once isolated, the fusions were subcloned onto a
mycobacterial shuttle vector, pMB198, that contains the attP/int L5 mycobacte-
riophage integration attachment system, which promotes integration into the
chromosome in single copy (25).
Isolation of azide-resistant alleles of M. bovis BCG SecA. Plasmid pYUB499
was subjected to N-methyl-N-nitro-N-nitrosoguanidine (Sigma) mutagenesis
(30). Mutagenized DNA was electroporated into mc2155, and azide-resistant
cells were selected on 7H10 agar plates containing sodium azide at 25 g/ml. This
concentration of sodium azide was chosen on the basis of azide sensitivity disk
assays that determined the minimum amount of sodium azide capable of inhib-
iting growth of M. smegmatis on 7H10 agar plates.
Azide sensitivity disk assays. Cells were grown in LB to saturation. A 0.1-ml
volume of saturated culture was mixed with molten LB top agar and plated on an
LB plate. Seven-millimeter-diameter paper filter disks (Schleicher & Schuell)
were then placed on the hardened top agar. To each disk, 10 l of 0.3 M sodium
azide was added. The zone of sensitivity was calculated as the diameter of
clearing around the disk minus the diameter of the disk.
Preparation of whole-cell protein extracts from M. smegmatis and Western
analysis. Strains were grown to an A600 of 0.5 to 1.0 in 7H9–1 ADS–glycerol–
0.1% Tween 80–kanamycin at 20 g/ml. The same number of cells, 1.2  109, was
harvested by centrifugation. The cells were washed twice in phosphate-buffered
saline–0.02% Tween 80, pelleted by centrifugation, quick-frozen in a dry-ice
–ethanol bath, and stored at 20°C. At a later time, the pellets were resuspended
in 200 l of extraction buffer (50 mM Tris-HCl [pH 7.5], 5 mM EDTA, 0.6%
sodium dodecyl sulfate [SDS], 10 g/ml aprotinin, E-64 at 10 g/ml, leupeptin at
10 g/ml, Pefabloc SC at 500 g/ml, pepstatin A at 10 g/ml) to which 200 l of
106-m glass beads was added. The cells and beads were then vortexed twice for
5 min at 4°C with a 5-min rest on ice. A 200-l volume of 2 SDS-polyacryl-
amide gel electrophoresis (PAGE) sample buffer was added to each sample. The
samples were denatured by boiling, and 20 l was loaded onto an SDS-PAGE
gel. The proteins were transferred to nitrocellulose, and Western analysis to
detect PhoA or hemagglutinin (HA) was carried out with anti-PhoA polyclonal
antibodies obtained from 5 Prime-3 Prime, Inc., or anti-HA monoclonal anti-
bodies obtained from Covance, Inc.
Nucleotide sequence accession numbers. The nucleotide sequences reported
here have been submitted to the GenBank database and assigned the following
accession numbers: M. smegmatis secA1, U66081; M. smegmatis secA2, AF287049;
M. bovis BCG, U66080.
RESULTS
Cloning of mycobacterial secA homologues. At the start of
this study, a minimal number of secA genes had been cloned.
By using available sequences from E. coli, B. subtilis, and P.
lutherii, degenerate oligonucleotide primers were designed to a
region of identity in the amino termini of these proteins (see
Materials and Methods). These primers were used to amplify
an approximately 250-bp PCR product from both M. bovis
BCG and M. smegmatis genomic DNAs. The resulting PCR
products were used to probe appropriate M. bovis BCG and M.
smegmatis genomic libraries and led to the cloning and se-
quencing of secA homologues from these two mycobacterial
species. These first secA genes we identified are named secA1.
M. bovis BCG secA1 and M. smegmatis secA1 encode proteins
with predicted sizes of 106 and 107 kDa, respectively. Subse-
quently, a secA1 homologue (rv3240c) was identified in the
complete genome sequence of M. tuberculosis (8). Each of
these secA1 genes encodes a protein with significant sequence
similarity to SecA1 in other mycobacterial species and to the
SecA proteins of other bacteria (Table 3). Southern analysis
with secA1 probes revealed hybridizing restriction fragments in
the genomic DNAs of all of the mycobacterial species tested.
This Southern analysis was consistent with secA1 being a sin-
gle-copy gene; there was no indication that another secA gene
existed in the mycobacterial genome (data not shown).
Based on the above-described work and the fact that the
other fully sequenced bacterial genomes that were available at
the time contained only one secA homologue, we were sur-
prised to see a second and distinct secA homologue present in
the genome sequence of M. tuberculosis (8). This second secA
homologue has been named secA2. M. tuberculosis secA2 cor-
responds to open reading frame rv1821 and encodes a protein
with a predicted size of 89 kDa. By Southern analysis, we
identified secA2-hybridizing fragments in the H37Rv and Erd-
TABLE 3. Amino acid similarities between M. tuberculosis






Mycobacterium tuberculosis SecA1 Z95121 100.0 50.2
Mycobacterium bovis BCG SecA1 U66080 98.6 50.8
Mycobacterium smegmatis SecA1 U66081 88.0 50.2
Mycobacterium leprae SecA1 P57996 90.4 48.5
Mycobacterium tuberculosis SecA2 Z78020 50.2 100.0
Mycobacterium smegmatis SecA2 AF287049 50.2 86.4
Mycobacterium leprae SecA2 O32922 50.1 90.8
Corynebacterium glutamicum SecA D17428 74.9 46.1
Streptomyces coelicolor SecA U21192 73.4 49.1
Synechococcus sp. strain PCC7942 SecA Q55357 63.6 44.8
Staphylococcus aureus SecA-1 BAB41941 63.3 51.2
Staphylococcus aureus SecA-2 BAB43747 49.9 46.5
Listeria monocytogenes SecA P47847 61.1 46.5
Streptococcus pneumoniae SecA-1 AE005672 60.2 50.8
Streptococcus pneumoniae SecA-2 AE005672 52.3 47.8
Escherichia coli SecA P10408 60.9 49.2
Bacillus subtilis SecA P28366 60.6 49.0
Pisum sativum SecA Q41062 59.5 46.8
Caulobacter crescentus SecA P38380 59.4 50.1
Actinobacillus actinomycetemcomitans SecA AF116183 59.2 48.4
Haemophilus influenzae SecA U32772 58.9 48.4
Neisseria meningitidis MC58 SecA AAF41891 58.2 47.7
Helicobacter pylori SecA O25475 57.3 47.7
Pavlova lutherii SecA QO1570 55.5 46.1
Borrelia burgdorferi SecA OO7497 54.6 47.6
Mycoplasma genitalium SecA P47318 50.9 44.1
a Percent similarity was determined by Gap Comparison with GCG.
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man strains of M. tuberculosis, M. bovis BCG, and M. smegmatis
(data not shown). We used the M. tuberculosis secA2 gene as a
probe with which to screen an M. smegmatis genomic library to
clone and sequence M. smegmatis secA2. The predicted size of
M. smegmatis SecA2 is 87 kDa.
Reproducibly, when a secA1 or secA2 probe was used for
Southern analyses (high and low stringency in nature) only a
single secA gene, corresponding to the probe used, was iden-
tified (data not shown). This is consistent with the difference in
nucleotide sequence (50%) between the two secA genes. At the
amino acid level, SecA1 and SecA2 are only 50% similar. An
alignment of the two predicted proteins reveals that SecA2 is a
smaller protein with a shorter carboxy terminus (Fig. 1). E. coli
SecA contains two ATP-binding sites (ABCI and ABCII) that
are important to SecA function (31). Both SecA1 and SecA2
exhibit strong homology to the proposed Walker A and B
motifs present in these sites (Fig. 1), suggesting that both might
have physiological functions similar to those of E. coli SecA.
Determination of the essentiality of secA1 and secA2. In
other bacteria in which SecA has been studied, SecA is essen-
tial and encoded by a single-copy gene (17, 34, 43). One ex-
planation for the presence of two secA genes in mycobacteria
is that they encode redundant functions. In this scenario, de-
letion of either secA gene alone would not be lethal because
the remaining homologue would compensate for the absence
of the other. To determine the essential nature of each SecA
protein in mycobacteria, we tested whether it is possible to
delete either secA gene.
We used a two-step allelic-exchange strategy to determine
the essentiality of each secA gene. This approach has previ-
ously been used in M. smegmatis (22, 36). In the first step, a
suicide vector containing an in-frame deletion of a given secA
gene, a selectable hyg (encoding hygromycin resistance)
marker, and a counterselectable sacB marker is integrated into
the chromosome by means of a single homologous recombi-
nation event between the secA allele on the vector and the
wild-type secA allele in the chromosome. The resulting recom-
binant strain is referred to as a single-crossover strain, and it
contains a tandem duplication of the secA region (both a mu-
tated and a wild-type allele are present in the chromosome)
separated by vector sequences including sacB and hyg (dia-
grams of such strains are shown in Fig. 2B and 3B). The second
step is to select recombinants that have undergone a second
homologous recombination event between the two secA alleles.
Depending on the site of this second recombination event, it
leaves either a mutant or a wild-type allele in the chromosome.
This second recombination event also eliminates the interven-
ing vector sequences, including sacB and hyg. Expression of
sacB results in sensitivity to sucrose; therefore, these secondary
recombinants are selected as sucrose-resistant colonies (38).
FIG. 1. Alignment of SecA proteins from B. subtilis, E. coli, and M. smegmatis (SecA1 and SecA2). ABCI (high-affinity ATP-binding site) and
ABCII (low-affinity ATP-binding site) are indicated. The lightning bolt indicates the threonine residue that can be mutated to produce azide
resistance. Triangles represent the deletion junction points in the 	secA1 mutation. The arrows pointing down identify the deletion junction points
in the 	secA2 mutation.
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The failure to obtain recombinants in which the secA gene is
deleted strongly suggests that it is an essential gene. If the
inability to delete the chromosomal secA gene is overcome in
merodiploid strains that contain an extra copy of secA, it dem-
onstrates the absolute requirement of that secA gene for via-
bility.
secA1 is essential in M. smegmatis. We first applied this
approach to the secA1 gene of M. smegmatis. Suicide plasmid
pMB128 contains a 1,278-bp in-frame deletion within M. smeg-
matis secA1. This deletion will generate a mutated protein
comprising 531 amino acids (in comparison to the wild-type
protein of 957 amino acids). Importantly, the deletion involves
both ATP-binding sites (Fig. 1). This plasmid was electropo-
rated into M. smegmatis, and hygromycin-resistant transfor-
mants were obtained. One of these transformants, MB526, was
used in the subsequent experiments. MB526 is the product of
a single-crossover event between the secA1 deletion allele on
pMB128 and the wild-type secA1 allele on the chromosome, as
demonstrated by Southern analysis (Fig. 2B and E).
Following the growth of MB526 in the absence of hygromy-
cin, sucrose-resistant colonies were selected and then screened
for hygromycin sensitivity. Sucrose-resistant and hygromycin-
sensitive colonies have undergone a second recombination
event between the two secA1 alleles. The individual secA1
allele remaining in the resulting recombinants was assayed by
PCR and Southern analysis. All of the recombinants assayed
contained the wild-type allele (Table 4). This failure to obtain
secA1 deletion mutants strongly suggests that deletion of secA1
in M. smegmatis is a lethal event.
To confirm this interpretation, we created secA1 merodip-
loid strains by transformation of MB526 with plasmids express-
ing secA1 of M. smegmatis and M. bovis BCG (pYUB544 and
pYUB499, respectively). From these merodiploid single-cross-
over strains, sucrose-resistant and hygromycin-sensitive recom-
binants were obtained. In contrast to the results obtained with
starting strain MB526 or MB526 transformed with control vec-
tor pMV261, these merodiploid strains produced two classes of
recombinants: 	secA1 recombinants and wild-type secA1 re-
combinants (Table 4; Fig. 2). From these results, we concluded
that secA1 is an essential gene in M. smegmatis.
secA2 cannot functionally replace secA1. The essentiality of
secA1 in M. smegmatis suggested that secA1 and secA2 are not
redundant genes. However, if secA2 is not expressed under
these experimental conditions, secA1 and secA2 might still
have the same function. To address this possibility, we tested
whether a 	secA1 strain can be rescued by secA2 expression.
Single-crossover strain MB526 was independently electropo-
rated with the plasmids pMB208, pMB147, and pMB162,
FIG. 2. Southern analysis of secA1 recombinants in M. smegmatis. (A to D) The relevant BglII and BamHI restriction endonuclease sites are
denoted. The MscI probe used in this Southern analysis is represented by vertical lines below the diagram. Panels: A, diagram of the chromosomal
wild-type secA1 allele; B, diagram of secA1 single-crossover strain MB526; C, diagram of a chromosomal 	secA1 allele; D, diagram of pYUB544,
a multicopy plasmid present in merodiploid strains; E, Southern blot of BglII-digested genomic DNAs probed with the secA1 probe. Sizes of
fragments are indicated on the left. Lanes: 1, mc2155; 2, MB526; 3, 	secA1 recombinant with pYUB544; 4, wild-type recombinant with pYUB544.
6984 BRAUNSTEIN ET AL. J. BACTERIOL.
which all carry the secA2 gene under control of the constitutive
hsp60 promoter. Vector pMB208 is a multicopy vector express-
ing M. smegmatis secA2, while pMB147 and pMB162 are mul-
ticopy and single-copy vectors, respectively, that express M.
tuberculosis secA2. Secondary recombination products were se-
lected from these recombinant strains. None of these secA2
expression constructs enabled the production of 	secA1 mu-
tants (Table 4).
secA2 is not essential in M. smegmatis. The essential nature
of secA2 in M. smegmatis was also evaluated. Suicide plasmid
pMB160 contains an in-frame deletion of 1,296 bp within M.
smegmatis secA2. This deletion produces a mutated protein of
366 amino acids (in comparison to the wild-type protein of 798
amino acids). Once again, the ATP-binding sites are included
in the deletion (Fig. 1). By using pMB160, single-crossover
strain MB573 was constructed (Fig. 3). From MB573, sucrose-
resistant and hygromycin-sensitive secondary recombinants
were identified. Some of these recombinants contained the
	secA2 deletion. One of these 	secA2 mutants, mc22522, was
used in all of the subsequent analyses presented in this report.
A separate secA2 single-crossover strain, MB575, similarly led
to the production of 	secA2 mutants. The ability to delete
secA2 demonstrates that it is not an essential gene. To our
knowledge, this is the first secA that has been shown to be
nonessential.
The secA2 mutant exhibits a growth defect on rich agar
plates. Shortly after generating mc22522, we observed that
when grown on rich medium (LB or Mueller-Hinton) agar
plates, it produces smaller single colonies than those of wild-
type M. smegmatis strain mc2155 (Fig. 4). This small-colony
phenotype is medium dependent; it is not seen on minimal
agar plates (7H10). Furthermore, there is no observable
growth defect associated with mc22522 when it is grown in rich
liquid medium.
We do not understand the basis of this phenotype. However,
it is clear that it is due to the deletion mutation in secA2. Even
though strain mc22522 contains an in-frame deletion in secA2,
which should avoid any polar effects on other genes, we per-
formed complementation analysis. We transformed mc22522
FIG. 3. Southern analysis of secA2 recombinants in M. smegmatis.
(A to C) BamHI restriction endonuclease sites are denoted. The
BamHI-HindIII probe used in this Southern analysis is indicated by
vertical bars below the diagram. Panels: A, diagram of the chromo-
somal wild-type secA2 allele; B, diagram of secA2 single-crossover
strain MB573; C, diagram of chromosomal 	secA2 allele; D, Southern
blot of BamHI-digested genomic DNAs probed with the secA2 probe.
Sizes of fragments are indicated on the left. Lanes: 1, mc2155; 2,
MB573; 3, 	secA2 (mc22522 produced from MB573); 4, wild-type
recombinant produced from MB573.
FIG. 4. Growth defect of the 	secA2 mutant on rich medium agar
plates. Single colonies of 	secA2 mutant mc22522, wild-type mc2155,
and complemented 	secA2 attB::secA2 strain mc22522/pMB162 are
shown on Mueller-Hinton plates grown at 37°C.
TABLE 4. Secondary recombination products produced
from single-crossover strains
Strain (plasmid)




MB526 0 100 13
MB526(pMV261) 0 100 9
MB526(pYUB544) 62 38 16
MB526(pYUB499) 59 41 39
MB526(pMB208) 0 100 20
MB526(pMB147) 0 100 24
MB526(pMB162) 0 100 19
secA2 single crossover
MB573 31 69 13
MB575 50 50 18
a Number of sucrose-resistant and hygromycin-sensitive recombinants ana-
lyzed.
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with pMB162, which integrates into the mycobacterial chro-
mosome and expresses the secA2 gene of M. tuberculosis from
the constitutive hsp60 promoter. The introduction of this secA2
expression construct successfully rescued the small-colony phe-
notype of mc22522, demonstrating that this phenotype is the
result of the secA2 mutation.
Since SecA1 and SecA2 both share significant homology to
other SecA proteins, we tested whether increased expression of
secA1 could suppress the small-colony phenotype of mc22522.
To our surprise, not only did overexpression of SecA1 not
suppress the phenotype, it exacerbated the growth defect (Fig.
5). An extra copy of secA1 integrated into the chromosome of
mc22522 causes a reduction in colony size, while expression of
secA1 from a multicopy vector has an even more dramatic
effect. This same result was obtained with the secA1 genes of
both M. bovis BCG and M. smegmatis. This effect on the
	secA2 phenotype was seen only on rich agar plates and was
specific for a 	secA2 background, since overexpression of
secA1 in wild-type parent strain mc2155 has no obvious effect
on colony size. This synthetic phenotype between 	secA2 and
high-level expression of secA1 is suggestive of a relationship
between these two genes.
The secA2 mutant is supersensitive to azide. In E. coli,
sodium azide inhibits protein export both in vivo and in vitro
(35). Furthermore, SecA has been shown to be the major
essential target of sodium azide, as azide-resistant mutants
map to secA in E. coli (21, 35). Therefore, we investigated
whether the presence of SecA2 influences the azide sensitivity
of M. smegmatis.
Since azide sensitivity has not previously been studied in
mycobacteria, we first set out to determine whether sodium
azide similarly acts to inhibit SecA in mycobacteria. We tested
whether specific mutations in secA1 can confer azide resistance
on M. smegmatis. Multicopy plasmid pYUB499, which contains
secA1 from M. bovis BCG, was subjected to chemical mutagen-
esis and introduced into mc2155. Azide-resistant transformants
were selected on plates containing azide and arose at a fre-
quency of 104. The azide resistance of one transformant was
shown to segregate with the mutagenized plasmid, designated
pYUB538, by means of retransformation experiments. Se-
quence analysis of the secA1 gene on pYUB538 revealed a
G-to-A mutation at base pair 386. This mutation results in
replacement of threonine 129 with isoleucine in ABCI (Fig. 1).
The corresponding mutation in secA of B. subtilis, replacement
of threonine 128 with isoleucine, has previously been reported
to produce azide resistance (32). Thus, this test provided com-
pelling evidence that sodium azide acts in a similar fashion on
SecA1 in mycobacteria.
To measure the impact of SecA2 on the azide sensitivity of
M. smegmatis, a disk assay was employed (see Materials and
Methods). The zone of clearing around an azide-soaked disk
was used as the measure of azide sensitivity. This assay clearly
demonstrated that the 	secA2 mutant is supersensitive to
azide. While wild-type mc2155 had a zone of sensitivity of 17.7
mm, mc22522 exhibited a 31.3-mm zone of sensitivity. The
complemented strain, mc22522 with pMB162, exhibited an in-
termediate zone of sensitivity of 20.3 mm. This increased azide
sensitivity of mc22522 was similarly observed in a liquid MIC
analysis (data not shown). This supersensitivity phenotype is
specific to azide and is not a pleiotropic effect of altered cell
wall permeability. The sensitivity of mc22522 to a collection of
drugs including streptomycin, isoniazid, rifampin, ampicillin,
and vancomycin was unchanged. Given the relationship be-
tween azide and SecA, we believe that this supersensitivity
phenotype reflects a role for SecA2 in assisting SecA1 in the
essential Sec pathway.
SecA2 functions in protein export. The azide supersensitivity
phenotype suggested that SecA2 plays a role in assisting SecA1
in protein export. The strong homology of SecA2 to other
SecA proteins also suggested a role in protein export. There-
fore, we set out to determine whether cells lacking secA2 ex-
hibit a defect in protein export.
To monitor protein export, we used immunoblot analysis of
exported PhoA (E. coli alkaline phosphatase) fusion proteins
to ascertain whether protein export occurs normally or
whether unprocessed precursor proteins accumulate intracel-
lularly (indicative of a defect in protein export). Each of the
fusions analyzed had an exported M. tuberculosis protein
(FbpB [antigen 85B, Rv1886c], Rv1566c, or PepA [Rv0125])
fused at the amino terminus of a truncated PhoA protein
lacking its endogenous signal sequence. These fusions were
recently isolated in a genetic screen to identify M. tuberculosis
proteins that are exported in the host strain of M. smegmatis
(5). We, and others, have observed that often when exported
PhoA fusion proteins are expressed in M. smegmatis and de-
tected by Western analysis of whole-cell extracts, the products
identified do not migrate at the expected molecular weight of
the fusion protein (6, 49). Rather, different fusion proteins
lead to the production of similar, smaller PhoA-reactive prod-
ucts that are near the size expected for native PhoA. Although
the size of these products is unexpected, we believe that they
FIG. 5. The 	secA2 mutant is sensitive to overexpression of secA1.
(A) 	secA2 mutant mc22522 transformed with various plasmids.
Lanes: 1, pMV261; 2, pMB175 (single-copy secA1); 3, pYUB499 (mul-
ticopy secA1). (B) mc2155 transformed with various plasmids. Lanes: 1,
pMV261; 2, pYUB499. Colonies were grown on Mueller-Hinton agar
plates at 37°C.
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reflect exported PhoA fusions. This is based on the findings
that these PhoA fusion proteins exhibit phosphatase activity
(indicating export out of the cytoplasm) and that they contain
recognizable signal sequences. We propose that these smaller
PhoA-reactive products arise by proteolysis that occurs follow-
ing export to the cell wall. In E. coli, a similar proteolytic
degradation near the PhoA fusion junction of some exported
PhoA fusion proteins has been observed (23). Given this prop-
erty of PhoA fusions in M. smegmatis, we predicted that a
defect in the export of these proteins would result in a decrease
in the degradation of the fusions, yielding an increase in the
amount of full-length fusion inside the cells.
When either the FbpB-HA-PhoA or the Rv1566c-PhoA
fusion is expressed in wild-type mc2155, bands between 45 and
50 kDa are observed but no full-length fusion product is ob-
served (Fig. 6A, lanes 3 and 6). In contrast, when these same
fusion proteins are expressed in the 	secA2 mutant (mc22522),
the correct-sized full-length fusion product (76.4 kDa for
FbpB-HA-PhoA or 64.7 kDa for Rv1566c-PhoA) is observed,
along with a reduced amount of the proteolytic PhoA products
(Fig. 6A, lanes 5 and 8). We interpret this change in size as
reflecting the accumulation of the full-length fusion product in
the cytoplasm, where it is protected from cell wall proteases,
and showing that mc22522 exhibits a defect in the export of
these two fusion proteins.
In support of this interpretation, we found that when strains
MB648 (mc2155 expressing FbpB-HA-PhoA) and MB634
(mc2155 expressing Rv1566c-PhoA) were treated with azide,
the same full-length fusion protein appeared (Fig. 6A, lanes 4
and 7). Since this azide treatment should cripple the export
pathway by inactivating the essential SecA1 protein, and pos-
sibly SecA2 as well, we believe that the large product that
appears is a result of accumulation of the full-length fusion
protein in the cytoplasm. Finally, we confirmed that the prod-
FIG. 6. Immunoblot analysis of PhoA fusions in wild-type and 	secA2 (mc22522) strains. Whole-cell extracts from individual strains were
prepared, and 20-l volumes were loaded per lane for SDS-PAGE and Western analysis. (A) Anti-PhoA antibodies were used for Western analysis
of whole-cell extracts. Lanes: 1, MB509 (mc2155/pMV261); 2, mc22757 (mc2155/pMB174); 3, MB648 (mc2155/pMB206); 4, MB648 with azide
treatment; 5, MB649 (mc22522/pMB206); 6, MB634 (mc2155/pMB202); 7, MB634 with azide treatment; 8, MB635 (mc22522/pMB202). (B)
Anti-HA Western blot. Lanes: 1, MB648; 2, MB648 with azide treatment; 3, MB649. (C) Anti-PhoA Western blot. Lanes: 1, MB509; 2, mc22757;
3, MB624 (mc2155/pMB196); 4, MB625 (mc22522/pMB196). Marker sizes are indicated to the left in kilodaltons. Full-length FbpB-HA-PhoA and
Rv1566c-PhoA fusions are indicated by arrows. PhoA breakdown products are identified by a bracket near the bottom of the blots. The asterisks
indicate cross-reacting products. Strains grown overnight in the presence of sodium azide are indicated below the blot. Plasmid pMB174 expresses
phoA, pMB206 expresses an fbpB-HA-phoA fusion, pMB202 expresses an rv1566c-phoA fusion, and pMB196 expresses a pepA-phoA fusion.
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uct accumulating in mc22522 is the FbpB-HA-PhoA fusion
protein by taking advantage of an in-frame HA tag present in
the FbpB portion of the fusion. Western analysis with anti-HA
antibodies was carried out on MB648 (mc2155 expressing
FbpB-HA-PhoA), MB648 following treatment with azide, and
MB649 (mc22522 expressing FbpB-HA-PhoA) (Fig. 6B). This
analysis confirmed that the large product that appears in
mc22522 is the FbpB-HA-PhoA full-length fusion product.
In contrast, a PepA-PhoA fusion was not similarly affected.
When this fusion protein was expressed in either mc2155 or
mc22522, the same PhoA proteolytic products were observed
(Fig 6C). Neither strain led to production of the full-length
67.5-kDa fusion protein. From our studies so far, we conclude
that the export of some, but not all, proteins involves SecA2.
DISCUSSION
Mycobacteria have two different SecA proteins. The proper
localization of cell surface and secreted proteins is an impor-
tant aspect of mycobacterial physiology and pathogenesis. The
cell envelope of mycobacteria is an unusual structure that
presents unique barriers to protein secretion. Yet, the protein
export pathways of mycobacteria have remained uncharacter-
ized (5). The genome of M. tuberculosis contains homologues
of all of the Sec pathway components (5, 8), with the exception
of SecB, a protein that is not found in all Sec systems (19). In
addition, mycobacteria are known to secrete proteins that are
initially synthesized as precursors containing recognizable sig-
nal sequences at their amino termini. Simply based on this
information, it might appear that mycobacteria contain a typ-
ical Sec pathway for protein export beyond the cytoplasm.
However, as presented in this report, the mycobacterial Sec
pathway is unusual in that it has two SecA proteins. Although
SecA is ubiquitously present and highly conserved in bacteria,
the identification of organisms containing two secA genes is
new.
Both the mycobacterial SecA1 and SecA2 proteins exhibit
significant sequence similarity to other bacterial and plant
(plastid) SecA homologues, and both contain the hallmark
ATP-binding motifs (Table 3; Fig. 1). All of the mycobacteria
evaluated so far have both secA1 and secA2, including M. leprae
(9, 26). This is significant, given the reductive evolution that
has been documented in M. leprae—a smaller genome size and
44% of the genes being recognizable pseudogenes (9). The
evolutionary basis for two SecA proteins in mycobacteria is
unknown. If the two genes arose by a duplication event, it likely
took place a long time ago since the two SecA proteins are not
extremely similar to each other, but each is highly conserved in
different mycobacterial species. SecA1 exhibits higher se-
quence similarity with the other SecA homologues, including
that of the distantly related bacteria E. coli and B. subtilis, than
it does with mycobacterial SecA2 (Table 3).
SecA1 is a housekeeping SecA protein, and SecA2 is an extra
SecA protein. As a starting point for defining the roles played
by SecA1 and SecA2, we used allelic exchange to determine
whether each secA gene is essential. These experiments
showed that while secA1 is essential in M. smegmatis, secA2 is
not. In other bacteria, SecA is essential.
The essentiality of SecA1 leads us to believe that it repre-
sents the mycobacterial equivalent of E. coli SecA or the
housekeeping SecA protein. Our isolation of azide-resistant
mutations in SecA1 also supports this idea. We believe that
SecA1 acts together with the other mycobacterial Sec family
homologues to transport signal sequence-containing proteins
across the cytoplasmic membrane. However, definitive evi-
dence that SecA1 functions in this manner requires further
investigation and the construction of a conditional secA1 allele.
Our ability to generate a 	secA2 mutant demonstrates that
SecA2 is not essential. Although this mutation is not a full
deletion, we do not believe that the truncated protein retains
its function. Of the two ATP-binding sites, all but the A motif
of ABCI is deleted, which should eliminate all ATP-binding
and hydrolysis activity (Fig. 1). Furthermore, we have subse-
quently constructed a mutant of M. tuberculosis with a com-
plete deletion of secA2 that is also viable (M. Braunstein and
W. R. Jacobs, unpublished data). To our knowledge, this is the
first SecA protein that has been shown to be nonessential.
The role of SecA2 in mycobacteria. To begin to understand
the role of SecA2 in the cell, we examined whether SecA2 is
capable of carrying out the same functions as SecA1. The fact
that a mutant with a deletion of secA1 is inviable suggested that
SecA2 is not simply an equivalent copy of SecA1. However, it
remained a possibility that this result reflected a lack of ex-
pression of SecA2 under these experimental conditions. To
address this directly, we expressed secA2 from the constitutive
mycobacterial hsp60 promoter. By Western analysis, we saw
that the SecA2 protein was produced (data not shown); how-
ever, the requirement for SecA1 was not relieved by this ex-
pression of SecA2. This finding that SecA2 cannot functionally
replace SecA1 is consistent with the fact that the homology
shared between the two SecA proteins is only 50% (Table 3).
If SecA2 is not simply an extra copy of SecA1, what is the
role of SecA2? Based on the significant sequence homology
between SecA2 and other SecA homologues, we believed it
would be involved in protein export—perhaps the export of a
specific subset of proteins. Our subsequent analysis supports
this idea.
A phenotypic analysis of 	secA2 mutant mc22522 revealed
phenotypes that include a growth defect on rich agar plates.
The source of the phenotype is unclear. This growth phenotype
of mc22522 is exacerbated when secA1 is overexpressed, but
overexpression of secA1 in a wild-type background does not
have the same effect. This synthetic relationship between high
levels of SecA1 and the absence of SecA2 suggests that these
two SecA proteins interact with some of the same proteins or
each other. This is consistent with a role for SecA2 in protein
export. A possible explanation for this synthetic phenotype is
that when SecA2 is absent and SecA1 is overexpressed, non-
productive complexes between SecA1 and other essential Sec
factors arise, leading to an overall decrease in the efficiency of
protein export. This possibility will be explored in future ex-
periments.
The azide supersensitivity phenotype of mc22522 also sug-
gests an involvement of SecA2 in protein export. Azide poisons
ATPases, and SecA1 appears to be the most sensitive essential
ATPase in mycobacteria. For this reason, we interpret this
phenotype as indicative that azide has a greater effect on the
Sec pathway when SecA2 is not present to assist in the process.
The most direct experiment we undertook to identify a role
for SecA2 in the export of proteins was to monitor protein
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processing as a measure of protein translocation across the
cytoplasmic membrane. In looking at the steady-state levels of
three PhoA fusion proteins, we found that an FbpB-HA-
PhoA fusion and an Rv1566c-PhoA fusion are not as effi-
ciently exported in the 	secA2 mutant. It is important to em-
phasize that this export defect of mc22522 is not complete. The
immunoblots reveal a reduced amount of export (PhoA pro-
teolytic products), and the mc22522 strains expressing these
fusions still exhibit phosphatase activity (which is associated
with transport of the fusion protein out of the cytoplasm). In
contrast, we did not see any evidence of a defect in the export
of a PepA-PhoA fusion protein in mc22522. This finding re-
veals that SecA2 participates in the protein export of some,
perhaps not all, signal sequence-containing proteins.
We interpret our results as indicating a role for SecA2 in
protein export. An alternative explanation could be that SecA2
is a regulator of the level of SecA1. This idea is supported by
the demonstration in E. coli that SecA can regulate its own
expression (44). In examining Western analyses with the cur-
rently available reagents, there is no indication that the levels
of SecA1 are altered by the presence or absence of SecA2 in
the cell; therefore, we think this explanation for the role of
SecA2 unlikely (data not shown).
Two roles for SecA2 in mycobacteria. We propose that one
role for SecA2 is as a facilitator of protein export via the
primary Sec pathway involving SecA1. We believe that the
azide supersensitivity phenotype and export defect of some
signal sequence-containing PhoA fusion proteins reflect this
role of SecA2. There may be a collection of signal sequence-
containing presecretory proteins that are substrates for both
SecA1 and SecA2. Thus, when SecA2 is absent, there is an
impact on the overall efficiency of the pathway. We propose
that FbpB-PhoA and Rv1566c-PhoA are two such proteins,
since SecA2 participates, but dos not exclusively act, in their
export. In E. coli, B. subtilis, and Streptomyces lividans, SecA
has been shown to exist as a dimer (1, 3, 13, 47). Therefore, it
is also possible that SecA1 and SecA2 form mixed dimers and
that this species is important in the recognition of certain
substrates.
The findings that SecA2 cannot functionally replace SecA1
and that SecA2 is highly conserved throughout mycobacteria
lead us to believe that SecA2 has a second role in the cell.
This second role may be in the export of a distinct subset of
proteins that are exclusive or preferential substrates of SecA2.
The identities of those proteins have not been established, and
their identification awaits a more complete analysis of the
multitude of exported proteins. In order to identify these pro-
teins, it will be important to know the conditions under which
SecA2-specific protein export functions.
Research on numerous bacterial pathogens has repeatedly
demonstrated the importance of specialized protein secretion
systems to virulence. Many of the specialized export pathways
are present in pathogenicity islands. The genome of M. tuber-
culosis does not appear to have specialized export systems
homologous to those previously identified in other pathogens
(4). However, the recent identification of two secA genes in the
gram-positive pathogens S. aureus and S. pneumoniae raises
the interesting possibility that SecA2 is a component of a new
type of specialized protein export pathway that is important to
pathogenesis (24, 27, 48). SecA2 may represent a protein that
has maintained some of its abilities to function with SecA1 and
the other Sec family homologues in the primary Sec pathway
but has evolved to have a second function that is utilized under
a certain set of conditions to export a specific subset of pro-
teins.
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